CRMD
Cormedix Inc.
A biopharmaceutical company that makes Defencath, a catheter lock solution used by kidney-dialysis patients to prevent bloodstream infections and blood clotting. Founded in 2006 by Antony P. Pfaffle, the firm began life as Picton Holding Company and was renamed CorMedix a few months later. The name blends the Latin "cor" (heart) with "medix," a nod to the medical conditions it addresses.
CUSIP: 21900C308HealthcareUS1 holder
Total Value
$15.06M
Total Shares
2.44M
Net Share Change
-426.1K
Activity
1 selling
Investor
Value
Shares
Weight
Change
